Abstract
The transport of3H-histamine by the endocrine-specific (VMAT1) and neuronal (VMAT2) isoforms of the vesicular monoamine transporter has been evaluated in digitonin-permeabilized fibroblasts transfected with either VMAT1 or VMAT2. Transport of3H-histamine by both VMAT1 and VMAT2 was reserpine-sensitive but only transport by VMAT2 was inhibited by tetrabenazine. Maximal equilibrated levels of3H-histamine accumulation by VMAT2 (K m∼300 µM) were approximately three times greater than that mediated by VMAT1 when using a subsaturating concentration of exogenous3H-histamine (50 µM). The expression of VMAT2 in histaminergic neurons in the rat brain was examined with polyclonal antipeptide antibodies specific for VMAT1 or VMAT2. VMAT2-positive and tyrosine hydroxylase-negative immunoreactive cell bodies were localized to the ventral part of the posterior hypothalamus in the region of the mamillary nuclei. The transport properties of VMAT2 and the distribution of VMAT2 in cell bodies in the tuberomammillary nucleus of the posterior hypothalamus reported here and the apparent absence of VMAT1 and VMAT2 in tissue mast cells support previous findings of reserpine-sensitive and reserpine-resistant pools of histamine in brain and peripheral tissues.
Similar content being viewed by others
References
Atack C. (1971) Reduction of histamine in mouse brain by N1-(D. L-seryl)-N2-(2,3,4-trihydroxybenzyl) hydrazine and reserpine.J. Pharm. Pharmacol. 23, 992,993.
Atack C. and Carlsson A. (1972) In vitro release of endogenous histamine, together with noradrenaline and 5-hydroxytryptamine, from slices of mouse cerebral hemispheres.J. Pharm. Pharmacol. 24, 990–992.
Buu N. T. (1989) Modification of vesicular dopamine and norepinephrine by monoamine oxidase inhibitors.Biochem. Pharmacol. 38, 1685–1692.
Dismukes H. and Snyder S. H. (1974) Histamine turnover in rat brain.Brain Res. 78, 467–481.
Erickson J. D., Eiden L. E., and Hoffman B. (1992) Expression cloning of a reserpine-sensitive vesicular monoamine transporter.Proc. Natl. Acad. Sci. USA 89, 10,993–10,997.
Erickson J. D. and Eiden L. E. (1993) Functional identification and molecular cloning of a human brain vesicle monoamine transporter.J. Neurochem. 61, 2314–2317.
Erickson J. D., Schafer M. K.-H., Bonner T. I., Eiden L. E., and Weihe E. (1996) Distributions in neuronal and endocrine cells and distinct pharmacological properties of two isoforms of the human vesicular monoamine transporter.Proc. Natl. Acad. Sci. USA, in press.
Fuerst T. R., Niles E. G., Studier F. W., and Moss B. (1986) Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.Proc. Natl. Acad. Sci. USA 83, 8122–8126.
Garbarg M., Barbin G., Bischoff S., Pollard H., and Schwartz J. C. (1976) Dual localization of histamine in an ascending neuronal pathway and in non-neuronal cells evidenced by lesions in the lateral hypothalamic area.Brain Res. 106, 333–348.
Garbarg M., Barbin G., Rodergas E., and Schwartz J. C. (1980) Inhibition of histamine synthesis in brain by α-fluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies.J. Neurochem. 35, 1045–1052.
Gonzalez A. M., Walther D., Pazos A., and Uhl G. A. (1994) Synaptic vesicular monamine transporter expression: distribution and pharmacologic profile.Mol. Brain Res. 22, 219–226.
Green H. and Erickson R. W. (1964) Effect of some drugs upon rat brain histamine content.Int. J. Neuropharmacol. 3, 315–320.
Hakanson R., Bottcher G., Ekblad E., Panula P., Simonsson M., Dohlsten M., Hallberg T., and Sundler F. (1986) Histamine in endocrine cells in the stomach: a survey of several species using a panel of histamine antibodies.Histochemistry 86, 5–17.
Hough L. and Domino E. (1979) Tele-methylhistamine oxidation by type B monoamine oxidase.J. Pharmacol. Exp. Ther. 208, 422–428.
Kanner B. I. and Bendahan A. (1985) Transport of 5-hydroxytryptamine in membrane vesicles from rat basophilic leukemia cells.Biochim. Biophys. Acta 816, 403–410.
Liu Y., Peter D., Roghani A., Schuldiner S., Prive G. G., Eisenberg D., Brecha N., and Edwards R. H. (1992) A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter.Cell 70, 539–551.
Maeyama K., Watanabe T., Yamatodani A., and Wada H. (1983) Effect of α-fluoromethylhistidine on the histamine content of the brain of W/W mice devoid of mast cells: turnover of brain histamine.J. Neurochem. 41, 128–134.
Martres M. P., Baudry M., and Schwartz J. C. (1975) Histamine synthesis in the developing rat brain: evidence for multiple compartmentation.Brain Res. 83, 261–275.
Menckel A. and Edwards, R. H. (1995) Transport of histamine by vesicular monoamine transporter-2.Neuropharmacology 34, 1543–1547.
Metcalfe D. D., Costa J. J., and Burd P. R. (1992) Mast cells and basophils, inInflammation: Basic Principles and Clinical Correlates, 2nd ed. (Gallin J. I., Goldstein I. M., and Snyderman R., eds.), Raven, New York, pp. 709–725.
Moran N. C. and Westerholm B. (1963) The influence of reserpine on hydroxytryptamine and histamine content of rat mast cells and of some rat tissues.Acta Physiol. Scand. 58, 20–29.
Muroi N., Oishi R., and Saeki K. (1991) Effect of reserpine on histamine metabolism in the mouse brain.J. Pharmacol. Exp. Ther. 256, 967–972.
Oishi R., Nishibori M., and Saeke K. (1984) Regional differences in the turnover of neuronal histamine in the rat brain.Life Sci. 34, 691–699.
Parratt J. R. and West G. B. (1957) Release of 5-hydroxytryptamine and histamine from tissues of the rat.J. Physiol. (Lond.) 137, 179–192.
Peter D., Jimenez J., Liu Y., Kim J., and Edwards R. H. (1994) The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors.J. Biol. Chem. 269, 7231–7237.
Peter D., Liu Y., Sternini C., de Giorgio R., Brecha N., and Edwards R. H. (1995) Differential expression of two vesicular monoamine transporters.J. Neurosci. 15, 6179–6188.
Pollard H., Bischoff S., and Schwartz J. C. (1973) Increased synthesis and release of3H-histamine in rat brain by reserpine.J. Pharm. Pharmacol. 25, 920–922.
Romeo H. E., Fink T., Yanaihara N., and Weihe E. (1994) Distribution and relative proportions of neuropeptide Y- and proenkephalin-containing noradrenergic neurones in rat superior cervical ganglion: separate projections to submaxilliary lymph nodes.Peptides 15, 1479–1487.
Russell W. L., Henry D. P., Phebus L. A., and Clemens J. A. (1990) Release of histamine in rat hypothalamus and corpus striatum in vivo.Brain Res. 512, 95–101.
Schafer M. K.-H., Nohr D., Romeo H., Eiden L. E., and Weihe E. (1994) Pan-neuronal expression of chromogranin A in rat nervous system.Peptides 15, 263–279.
Schayer R. W. and Reilly M. A. (1973) Formation and fate of histamine in rat and mouse brain.J. Pharmacol. Exp. Ther. 184, 33–40.
Schwartz J. C., Pollard H., Bischoff S., Rehault M. C., and Verdiere M. (1971) Catabolism of3H-histamine in the rat brain after intracisternal administration.Eur. J. Pharmacol. 16, 326–335.
Schwartz J. C., Lampart C., and Rose C. (1972) Histamine formation in rat brain in vivo: effects of histidine loads.J. Neurochem. 19, 801–810.
Schwartz J.-C., Arrang J.-M., Garbarg M., Pollard H., and Ruat M. (1991) Histaminergic transmission in the mammalian brain.Physiol. Rev. 71, 1–51.
Schuldiner S., Shirvan A., and Linial M. (1995) Vesicular neurotransmitter transporters: from bacteria to humans.Physiol. Rev. 75, 369–392.
Stitzel R. E. (1977) The biological fate of reserpine.Pharmacol. Rev. 28, 179–205.
Steinbusch H. W. M. (1991) Distribution of histaminergic neurons and fibers in rat brain.Acta Otalaryngol. 479, 12–23.
Sugimoto K., Maeyama K., Alam M. K., Sakurai E., Onoue H., Kasugai T., Kitamura Y., and Watanabe T. (1995) Brain histaminergic system in mast cell-deficient (Ws/Ws) rats: histamine content, histidine decarboxylase activity, and effects of (S) α-fluromethylhistidine.J. Neurochem. 65, 791–797.
Taylor K. M. and Snyder S. H. (1971) Histamine in rat brain: sensitive assay of endogenous levels, formation in vivo and lowering by inhibitors of histidine decarboxylase.J. Pharmacol. Exp. Ther. 179, 619–633.
Taylor K. M. and Snyder S. H. (1972) Dynamics of the regulation of histamine levels in mouse brain.J. Neurochem. 19, 341–354.
Taylor K. M. and Snyder S. H. (1973) The release of histamine from tissue slices of rat hypothalamus.J. Neurochem. 21, 1215–1223.
Verdiere M., Rose C., and Schwartz J. C. (1975) Synthesis and release of histamine studied on slices from rat hypothalamus.Eur. J. Pharmacol. 34, 157–168.
Wada H., Inagaki N., Yamatodani A., and Watanabe T. (1991) Is the histaminergic neuron system a regulatory center for whole-brain activity?Trends Neurosci. 14, 415–418.
Weihe E., Schafer M. K.-H., Erickson J. D., and Eiden L. E. (1994) Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat.J. Mol. Neurosci. 5, 149–164.
Weiner N. (1970) Regulation of norepinephrine biosynthesis.Ann. Rev. Pharmacol. 10, 273–290.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Erickson, J.D., Eiden, L.E., Schäfer, M.K.H. et al. Reserpine- and tetrabenazine-sensitive transport of3H-histamine by the neuronal isoform of the vesicular monoamine transporter. J Mol Neurosci 6, 277–287 (1995). https://doi.org/10.1007/BF02736786
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02736786